Drugs@FDA: FDA-Approved Drugs
New Drug Application (NDA): 022311
Company: GENZYME
Company: GENZYME
Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | TE Code | RLD | RS |
---|---|---|---|---|---|---|---|
MOZOBIL | PLERIXAFOR | 24MG/1.2ML (20MG/ML) | SOLUTION;SUBCUTANEOUS | Prescription | None | Yes | Yes |
Original Approvals or Tentative Approvals
Action Date | Submission | Action Type | Submission Classification | Review Priority; Orphan Status | Letters, Reviews, Labels, Patient Package Insert | Notes | Url |
---|---|---|---|---|---|---|---|
12/15/2008 | ORIG-1 | Approval | Type 1 - New Molecular Entity | PRIORITY; Orphan |
Label (PDF)
Letter (PDF) Review Summary Review (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2008/022311lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2008/022311s000ltr.pdf https://www.accessdata.fda.gov/drugsatfda_docs/nda/2008/022311s000TOC.cfm https://www.accessdata.fda.gov/drugsatfda_docs/nda/2008/022311s000_SumR.pdf |
Supplements
Action Date | Submission | Supplement Categories or Approval Type | Letters, Reviews, Labels, Patient Package Insert | Note | Url |
---|---|---|---|---|---|
08/19/2020 | SUPPL-22 | Labeling-Package Insert |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/022311s022lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2020/022311Orig1s022ltr.pdf | |
05/30/2019 | SUPPL-20 | Labeling-Package Insert |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/022311s020lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2019/022311Orig1s020ltr.pdf | |
12/01/2017 | SUPPL-18 | Labeling-Package Insert |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/022311s018lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2017/022311s018ltr.pdf | |
05/12/2016 | SUPPL-17 | Manufacturing (CMC) |
Label is not available on this site. |
||
08/04/2015 | SUPPL-16 | Labeling-Package Insert |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/022311s016lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2015/022311Orig1s016ltr.pdf | |
12/04/2014 | SUPPL-15 | Labeling-Package Insert |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/022311s015lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2014/022311Orig1s015ltr.pdf | |
11/12/2013 | SUPPL-14 | Manufacturing (CMC) |
Label is not available on this site. |
||
06/04/2013 | SUPPL-13 | Labeling-Package Insert, Labeling-Package Insert |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/022311s013lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2013/022311Orig1s013ltr.pdf | |
02/26/2013 | SUPPL-12 | Manufacturing (CMC) |
Label is not available on this site. |
||
06/14/2010 | SUPPL-1 | Labeling-Package Insert |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/022311s001lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2010/022311s001ltr.pdf |
Action Date | Submission | Supplement Categories or Approval Type | Letters, Reviews, Labels, Patient Package Insert |
Note | Url |
---|---|---|---|---|---|
08/19/2020 | SUPPL-22 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/022311s022lbl.pdf | |
05/30/2019 | SUPPL-20 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/022311s020lbl.pdf | |
12/01/2017 | SUPPL-18 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/022311s018lbl.pdf | |
08/04/2015 | SUPPL-16 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/022311s016lbl.pdf | |
12/04/2014 | SUPPL-15 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/022311s015lbl.pdf | |
06/04/2013 | SUPPL-13 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/022311s013lbl.pdf | |
06/04/2013 | SUPPL-13 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/022311s013lbl.pdf | |
06/14/2010 | SUPPL-1 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/022311s001lbl.pdf | |
12/15/2008 | ORIG-1 | Approval | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2008/022311lbl.pdf |